Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12-27

AUTHORS

A. Boilève, M. I. Carlo, P. Barthélémy, S. Oudard, D. Borchiellini, M. H. Voss, S. George, C. Chevreau, J. Landman-Parker, M-D Tabone, D. D. Chism, A. Amin, M. A. Bilen, D. Bosse, A. Coulomb-L’hermine, Xiaoping Su, T. K. Choueiri, Nizar M. Tannir, Gabriel G. Malouf

ABSTRACT

BackgroundMicrophthalmia Transcription Factor (MITF)family translocation renal cell carcinoma (tRCC) is a rare RCC subtype harboring TFE3/TFEB translocations. The prognosis in the metastatic (m) setting is poor. Programmed death ligand-1 expression was reported in 90% of cases, prompting us to analyze the benefit of immune checkpoint inhibitors (ICI) in this population.Patients and methodsThis multicenter retrospective study identified patients with MITF family mtRCC who had received an ICI in any of 12 referral centers in France or the USA. Response rate according to RECIST criteria, progression-free survival (PFS), and overall survival (OS) were analyzed. Genomic alterations associated with response were determined for 8 patients.ResultsOverall, 24 patients with metastatic disease who received an ICI as second or later line of treatment were identified. Nineteen (82.6%) of these patients had received a VEGFR inhibitor as first-line treatment, with a median PFS of 3 months (range, 1–22 months). The median PFS for patients during first ICI treatment was 2.5 months (range, 1–40 months); 4 patients experienced partial response (16,7%) and 3 (12,5%) had stable disease. Of the patients whose genomic alterations were analyzed, two patients with mutations in bromodomain-containing genes (PBRM1 and BRD8) had a clinical benefit. Resistant clones in a patient with exceptional response to ipilimumab showed loss of BRD8 mutations and increased mutational load driven by parallel evolution affecting 17 genes (median mutations per gene, 3), which were enriched mainly for O-glycan processing (29.4%, FDR = 9.7 × 10− 6).ConclusionsMITF family tRCC is an aggressive disease with similar responses to ICIs as clear-cell RCC. Mutations in bromodomain-containing genes might be associated with clinical benefit. The unexpected observation about parallel evolution of genes involved in O-glycosylation as a mechanism of resistance to ICI warrants exploration. More... »

PAGES

159

Journal

TITLE

Journal for ImmunoTherapy of Cancer

ISSUE

1

VOLUME

6

Author Affiliations

  • Department of Medical Oncology, Hôpital Universitaire Pitié-Salpétrière, Paris, France
  • Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
  • Service d’Hématologie et d’Oncologie, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France
  • U790 PARCC, European Georges Pompidou Hospital, René Descartes University, Paris, France
  • Centre Antoine Lacassagne, Nice, France
  • Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
  • IUCT-Oncopole, Institut Claudius-Regaud, Toulouse, France
  • Service d’Hématologie et d’Oncologie Pédiatrique, Hopital Armand-Trousseau, Paris, France
  • Division of Hematology and Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA
  • Carolinas Healthcare System, Levine Cancer Institute, Charlotte, NC, USA
  • Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  • Service d’Anatomopathologie, Hôpital Armand-Trousseau, Paris, France
  • Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Department of Hematology and Oncology, Centre Hospitalier Universitaire de Strasbourg, 1, Place de l’Hôpital, 67000, Strasbourg, France
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s40425-018-0482-z

    DOI

    http://dx.doi.org/10.1186/s40425-018-0482-z

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1110911755

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30591082


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adolescent", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents, Immunological", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Carcinoma, Renal Cell", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Child", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Child, Preschool", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genomics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunomodulation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kaplan-Meier Estimate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kidney Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Microphthalmia-Associated Transcription Factor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Multigene Family", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Staging", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Kinase Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Vascular Endothelial Growth Factor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Retrospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Translocation, Genetic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Young Adult", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Medical Oncology, H\u00f4pital Universitaire Piti\u00e9-Salp\u00e9tri\u00e8re, Paris, France", 
              "id": "http://www.grid.ac/institutes/grid.411439.a", 
              "name": [
                "Department of Medical Oncology, H\u00f4pital Universitaire Piti\u00e9-Salp\u00e9tri\u00e8re, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Boil\u00e8ve", 
            "givenName": "A.", 
            "id": "sg:person.01202757101.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202757101.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA", 
              "id": "http://www.grid.ac/institutes/grid.51462.34", 
              "name": [
                "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Carlo", 
            "givenName": "M. I.", 
            "id": "sg:person.013003741441.64", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013003741441.64"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Service d\u2019H\u00e9matologie et d\u2019Oncologie, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France", 
              "id": "http://www.grid.ac/institutes/grid.11843.3f", 
              "name": [
                "Service d\u2019H\u00e9matologie et d\u2019Oncologie, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Barth\u00e9l\u00e9my", 
            "givenName": "P.", 
            "id": "sg:person.01227445510.72", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227445510.72"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "U790 PARCC, European Georges Pompidou Hospital, Ren\u00e9 Descartes University, Paris, France", 
              "id": "http://www.grid.ac/institutes/grid.508487.6", 
              "name": [
                "Oncology Department, European Georges Pompidou Hospital, Ren\u00e9 Descartes University, Paris, France", 
                "Association pour la Recherche sur les Th\u00e9rapeutiques Innovantes en Canc\u00e9rologie, Paris, France", 
                "U790 PARCC, European Georges Pompidou Hospital, Ren\u00e9 Descartes University, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Oudard", 
            "givenName": "S.", 
            "id": "sg:person.01073375756.64", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073375756.64"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Centre Antoine Lacassagne, Nice, France", 
              "id": "http://www.grid.ac/institutes/grid.417812.9", 
              "name": [
                "Centre Antoine Lacassagne, Nice, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Borchiellini", 
            "givenName": "D.", 
            "id": "sg:person.0675207541.34", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675207541.34"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA", 
              "id": "http://www.grid.ac/institutes/grid.51462.34", 
              "name": [
                "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Voss", 
            "givenName": "M. H.", 
            "id": "sg:person.0577111044.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577111044.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA", 
              "id": "http://www.grid.ac/institutes/grid.240614.5", 
              "name": [
                "Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "George", 
            "givenName": "S.", 
            "id": "sg:person.01051777752.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051777752.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "IUCT-Oncopole, Institut Claudius-Regaud, Toulouse, France", 
              "id": "http://www.grid.ac/institutes/grid.417829.1", 
              "name": [
                "IUCT-Oncopole, Institut Claudius-Regaud, Toulouse, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chevreau", 
            "givenName": "C.", 
            "id": "sg:person.01327063503.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327063503.03"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Service d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique, Hopital Armand-Trousseau, Paris, France", 
              "id": "http://www.grid.ac/institutes/grid.413776.0", 
              "name": [
                "Service d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique, Hopital Armand-Trousseau, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Landman-Parker", 
            "givenName": "J.", 
            "id": "sg:person.01337717664.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337717664.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Service d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique, Hopital Armand-Trousseau, Paris, France", 
              "id": "http://www.grid.ac/institutes/grid.413776.0", 
              "name": [
                "Service d\u2019H\u00e9matologie et d\u2019Oncologie P\u00e9diatrique, Hopital Armand-Trousseau, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tabone", 
            "givenName": "M-D", 
            "id": "sg:person.0643123146.91", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643123146.91"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Hematology and Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA", 
              "id": "http://www.grid.ac/institutes/grid.412807.8", 
              "name": [
                "Division of Hematology and Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chism", 
            "givenName": "D. D.", 
            "id": "sg:person.01102635440.48", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102635440.48"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Carolinas Healthcare System, Levine Cancer Institute, Charlotte, NC, USA", 
              "id": "http://www.grid.ac/institutes/grid.468189.a", 
              "name": [
                "Carolinas Healthcare System, Levine Cancer Institute, Charlotte, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Amin", 
            "givenName": "A.", 
            "id": "sg:person.0616232204.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616232204.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.189967.8", 
              "name": [
                "Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bilen", 
            "givenName": "M. A.", 
            "id": "sg:person.0663317655.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663317655.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bosse", 
            "givenName": "D.", 
            "id": "sg:person.01252560751.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252560751.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Service d\u2019Anatomopathologie, H\u00f4pital Armand-Trousseau, Paris, France", 
              "id": "http://www.grid.ac/institutes/grid.413776.0", 
              "name": [
                "Service d\u2019Anatomopathologie, H\u00f4pital Armand-Trousseau, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Coulomb-L\u2019hermine", 
            "givenName": "A.", 
            "id": "sg:person.01131024035.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131024035.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
              "id": "http://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Su", 
            "givenName": "Xiaoping", 
            "id": "sg:person.016563315207.95", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016563315207.95"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Choueiri", 
            "givenName": "T. K.", 
            "id": "sg:person.01155331400.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155331400.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
              "id": "http://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tannir", 
            "givenName": "Nizar M.", 
            "id": "sg:person.01004561122.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004561122.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology and Oncology, Centre Hospitalier Universitaire de Strasbourg, 1, Place de l\u2019H\u00f4pital, 67000, Strasbourg, France", 
              "id": "http://www.grid.ac/institutes/grid.11843.3f", 
              "name": [
                "Department of Medical Oncology, H\u00f4pital Universitaire Piti\u00e9-Salp\u00e9tri\u00e8re, Paris, France", 
                "Service d\u2019H\u00e9matologie et d\u2019Oncologie, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France", 
                "Department of Functional Genomics and Cancer, Institut de G\u00e9n\u00e9tique et de Biologie Mol\u00e9culaire et Cellulaire, Illkirch, France", 
                "Department of Hematology and Oncology, Centre Hospitalier Universitaire de Strasbourg, 1, Place de l\u2019H\u00f4pital, 67000, Strasbourg, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Malouf", 
            "givenName": "Gabriel G.", 
            "id": "sg:person.01236645411.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236645411.07"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nchembio.1403", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027422113", 
              "https://doi.org/10.1038/nchembio.1403"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrurol.2014.162", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002943543", 
              "https://doi.org/10.1038/nrurol.2014.162"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature12222", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050842404", 
              "https://doi.org/10.1038/nature12222"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ng.997", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018041741", 
              "https://doi.org/10.1038/ng.997"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s40425-018-0319-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100689551", 
              "https://doi.org/10.1186/s40425-018-0319-9"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-12-27", 
        "datePublishedReg": "2018-12-27", 
        "description": "BackgroundMicrophthalmia Transcription Factor (MITF)family translocation renal cell carcinoma (tRCC) is a rare RCC subtype harboring TFE3/TFEB translocations. The prognosis in the metastatic (m) setting is poor. Programmed death ligand-1 expression was reported in 90% of cases, prompting us to analyze the benefit of immune checkpoint inhibitors (ICI) in this population.Patients and methodsThis multicenter retrospective study identified patients with MITF family mtRCC who had received an ICI in any of 12 referral centers in France or the USA. Response rate according to RECIST criteria, progression-free survival (PFS), and overall survival (OS) were analyzed. Genomic alterations associated with response were determined for 8 patients.ResultsOverall, 24 patients with metastatic disease who received an ICI as second or later line of treatment were identified. Nineteen (82.6%) of these patients had received a VEGFR inhibitor as first-line treatment, with a median PFS of 3\u2009months (range, 1\u201322\u2009months). The median PFS for patients during first ICI treatment was 2.5\u2009months (range, 1\u201340\u2009months); 4 patients experienced partial response (16,7%) and 3 (12,5%) had stable disease. Of the patients whose genomic alterations were analyzed, two patients with mutations in bromodomain-containing genes (PBRM1 and BRD8) had a clinical benefit. Resistant clones in a patient with exceptional response to ipilimumab showed loss of BRD8 mutations and increased mutational load driven by parallel evolution affecting 17 genes (median mutations per gene, 3), which were enriched mainly for O-glycan processing (29.4%, FDR\u2009=\u20099.7\u2009\u00d7\u200910\u2212\u20096).ConclusionsMITF family tRCC is an aggressive disease with similar responses to ICIs as clear-cell RCC. Mutations in bromodomain-containing genes might be associated with clinical benefit. The unexpected observation about parallel evolution of genes involved in O-glycosylation as a mechanism of resistance to ICI warrants exploration.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/s40425-018-0482-z", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2438793", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1049249", 
            "issn": [
              "2051-1426"
            ], 
            "name": "Journal for ImmunoTherapy of Cancer", 
            "publisher": "BMJ", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "6"
          }
        ], 
        "keywords": [
          "immune checkpoint inhibitors", 
          "translocation renal cell carcinoma", 
          "progression-free survival", 
          "median progression-free survival", 
          "renal cell carcinoma", 
          "checkpoint inhibitors", 
          "overall survival", 
          "clinical benefit", 
          "cell carcinoma", 
          "death ligand 1 (PD-L1) expression", 
          "first ICI treatment", 
          "multicenter retrospective study", 
          "ligand 1 expression", 
          "first-line treatment", 
          "line of treatment", 
          "genomic alterations", 
          "clear cell RCC", 
          "metastatic setting", 
          "ICI treatment", 
          "stable disease", 
          "referral center", 
          "RECIST criteria", 
          "metastatic disease", 
          "partial response", 
          "retrospective study", 
          "aggressive disease", 
          "mechanisms of resistance", 
          "patients", 
          "exceptional responders", 
          "response rate", 
          "RCC subtypes", 
          "VEGFR inhibitors", 
          "exceptional response", 
          "warrants exploration", 
          "TFEB translocation", 
          "disease", 
          "carcinoma", 
          "resistant clones", 
          "treatment", 
          "inhibitors", 
          "months", 
          "survival", 
          "mutational load", 
          "genetic correlates", 
          "similar responses", 
          "alterations", 
          "mutations", 
          "response", 
          "prognosis", 
          "ResultsOverall", 
          "transcription factors", 
          "subtypes", 
          "responders", 
          "genes", 
          "Nineteen", 
          "benefits", 
          "RCC", 
          "unexpected observation", 
          "correlates", 
          "expression", 
          "population", 
          "setting", 
          "translocation", 
          "factors", 
          "O-glycosylation", 
          "criteria", 
          "cases", 
          "center", 
          "study", 
          "clones", 
          "rate", 
          "loss", 
          "resistance", 
          "mechanism", 
          "lines", 
          "USA", 
          "observations", 
          "France", 
          "exploration", 
          "glycan processing", 
          "load", 
          "parallel evolution", 
          "processing", 
          "evolution"
        ], 
        "name": "Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders", 
        "pagination": "159", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1110911755"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s40425-018-0482-z"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30591082"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s40425-018-0482-z", 
          "https://app.dimensions.ai/details/publication/pub.1110911755"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:45", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_775.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/s40425-018-0482-z"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40425-018-0482-z'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40425-018-0482-z'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40425-018-0482-z'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40425-018-0482-z'


     

    This table displays all metadata directly associated to this object as RDF triples.

    438 TRIPLES      21 PREDICATES      139 URIs      126 LITERALS      32 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s40425-018-0482-z schema:about N0242de6a8cab49928af3a0544ca21138
    2 N0c80495494f2488b828ade6b97458589
    3 N247ff5a976944032b57f55fa64658e37
    4 N26e163ecadc3462ebbe20eb36909fb1b
    5 N49355ce9145048dbbf0f65406909870d
    6 N5f3ff7618cc54925ada3e7b2e060ecd4
    7 N6280da8c4b704d0f84473e9f82bef06a
    8 N6fcaab14cf5346e6a3827b31303b4543
    9 N71308b0636ac483ca4af2f3f5bc9c1c2
    10 N78f1fcc04e384e5aaca5cf8b272403e4
    11 N81e6ce5803144115a5ea7f59c7f5cbac
    12 N8916de8adc1c440fbb160d5ccc8eaf91
    13 N8dc2727f21e94973a46811dd77e7d390
    14 N9d3df86ef4244545bb1e69622e75ea81
    15 Na726c0470e2f49f39b7e2d3518dee01d
    16 Na741db344a4c43c1bc88fd1ab6dd5c59
    17 Na8cef5dc81bc4722818fe461589e8cb0
    18 Nb0ccdbd87a6e46d29f8c441589e140d5
    19 Nb40d7cac071342889b6bc86c50ac249d
    20 Nb89033efb64b413584d069849192bc2c
    21 Ncc5a3e7d1b04443db668543eaad665f0
    22 Nd038508809bd456ca0761fd92ac0e577
    23 Nd86fc25903ca4600879421c3bcbdd400
    24 Ne133c6d98803403594301f4f6ad64ad8
    25 Ne2c7077a2414407381d9fda35d2c4e33
    26 anzsrc-for:06
    27 anzsrc-for:0604
    28 schema:author N3283bedd9dfc4b7ca6bd624024619f9c
    29 schema:citation sg:pub.10.1038/nature12222
    30 sg:pub.10.1038/nchembio.1403
    31 sg:pub.10.1038/ng.997
    32 sg:pub.10.1038/nrurol.2014.162
    33 sg:pub.10.1186/s40425-018-0319-9
    34 schema:datePublished 2018-12-27
    35 schema:datePublishedReg 2018-12-27
    36 schema:description BackgroundMicrophthalmia Transcription Factor (MITF)family translocation renal cell carcinoma (tRCC) is a rare RCC subtype harboring TFE3/TFEB translocations. The prognosis in the metastatic (m) setting is poor. Programmed death ligand-1 expression was reported in 90% of cases, prompting us to analyze the benefit of immune checkpoint inhibitors (ICI) in this population.Patients and methodsThis multicenter retrospective study identified patients with MITF family mtRCC who had received an ICI in any of 12 referral centers in France or the USA. Response rate according to RECIST criteria, progression-free survival (PFS), and overall survival (OS) were analyzed. Genomic alterations associated with response were determined for 8 patients.ResultsOverall, 24 patients with metastatic disease who received an ICI as second or later line of treatment were identified. Nineteen (82.6%) of these patients had received a VEGFR inhibitor as first-line treatment, with a median PFS of 3 months (range, 1–22 months). The median PFS for patients during first ICI treatment was 2.5 months (range, 1–40 months); 4 patients experienced partial response (16,7%) and 3 (12,5%) had stable disease. Of the patients whose genomic alterations were analyzed, two patients with mutations in bromodomain-containing genes (PBRM1 and BRD8) had a clinical benefit. Resistant clones in a patient with exceptional response to ipilimumab showed loss of BRD8 mutations and increased mutational load driven by parallel evolution affecting 17 genes (median mutations per gene, 3), which were enriched mainly for O-glycan processing (29.4%, FDR = 9.7 × 10− 6).ConclusionsMITF family tRCC is an aggressive disease with similar responses to ICIs as clear-cell RCC. Mutations in bromodomain-containing genes might be associated with clinical benefit. The unexpected observation about parallel evolution of genes involved in O-glycosylation as a mechanism of resistance to ICI warrants exploration.
    37 schema:genre article
    38 schema:isAccessibleForFree true
    39 schema:isPartOf N97c8313b753948d0bb83504c1df25bb9
    40 Nbcb0390d7c1349548b9a7ca12df43738
    41 sg:journal.1049249
    42 schema:keywords France
    43 ICI treatment
    44 Nineteen
    45 O-glycosylation
    46 RCC
    47 RCC subtypes
    48 RECIST criteria
    49 ResultsOverall
    50 TFEB translocation
    51 USA
    52 VEGFR inhibitors
    53 aggressive disease
    54 alterations
    55 benefits
    56 carcinoma
    57 cases
    58 cell carcinoma
    59 center
    60 checkpoint inhibitors
    61 clear cell RCC
    62 clinical benefit
    63 clones
    64 correlates
    65 criteria
    66 death ligand 1 (PD-L1) expression
    67 disease
    68 evolution
    69 exceptional responders
    70 exceptional response
    71 exploration
    72 expression
    73 factors
    74 first ICI treatment
    75 first-line treatment
    76 genes
    77 genetic correlates
    78 genomic alterations
    79 glycan processing
    80 immune checkpoint inhibitors
    81 inhibitors
    82 ligand 1 expression
    83 line of treatment
    84 lines
    85 load
    86 loss
    87 mechanism
    88 mechanisms of resistance
    89 median progression-free survival
    90 metastatic disease
    91 metastatic setting
    92 months
    93 multicenter retrospective study
    94 mutational load
    95 mutations
    96 observations
    97 overall survival
    98 parallel evolution
    99 partial response
    100 patients
    101 population
    102 processing
    103 prognosis
    104 progression-free survival
    105 rate
    106 referral center
    107 renal cell carcinoma
    108 resistance
    109 resistant clones
    110 responders
    111 response
    112 response rate
    113 retrospective study
    114 setting
    115 similar responses
    116 stable disease
    117 study
    118 subtypes
    119 survival
    120 transcription factors
    121 translocation
    122 translocation renal cell carcinoma
    123 treatment
    124 unexpected observation
    125 warrants exploration
    126 schema:name Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders
    127 schema:pagination 159
    128 schema:productId N091597ebedb84d2c98d140367ffdebb3
    129 N2921510a7459449db4e7637998385c2f
    130 Na7c8cbbd42924829a4ec90818772b02a
    131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110911755
    132 https://doi.org/10.1186/s40425-018-0482-z
    133 schema:sdDatePublished 2022-10-01T06:45
    134 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    135 schema:sdPublisher Na2562641f9d745bfa6ba7f378a8975ae
    136 schema:url https://doi.org/10.1186/s40425-018-0482-z
    137 sgo:license sg:explorer/license/
    138 sgo:sdDataset articles
    139 rdf:type schema:ScholarlyArticle
    140 N0242de6a8cab49928af3a0544ca21138 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Multigene Family
    142 rdf:type schema:DefinedTerm
    143 N091597ebedb84d2c98d140367ffdebb3 schema:name pubmed_id
    144 schema:value 30591082
    145 rdf:type schema:PropertyValue
    146 N09bd1e5de10a46b596eb8add25ca3272 rdf:first sg:person.0616232204.47
    147 rdf:rest Nc8de4895737c4dddac2767c007878858
    148 N0c80495494f2488b828ade6b97458589 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Male
    150 rdf:type schema:DefinedTerm
    151 N1728ca5ffcb64c6981bbb832a2cf1c05 rdf:first sg:person.0643123146.91
    152 rdf:rest Nebe9d7835bb64f9f91bb2a82d15eee17
    153 N1ed2c897e5bf4dfcb707a2ff37c24c9f rdf:first sg:person.01337717664.13
    154 rdf:rest N1728ca5ffcb64c6981bbb832a2cf1c05
    155 N247ff5a976944032b57f55fa64658e37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Receptors, Vascular Endothelial Growth Factor
    157 rdf:type schema:DefinedTerm
    158 N26e163ecadc3462ebbe20eb36909fb1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Biomarkers, Tumor
    160 rdf:type schema:DefinedTerm
    161 N2921510a7459449db4e7637998385c2f schema:name doi
    162 schema:value 10.1186/s40425-018-0482-z
    163 rdf:type schema:PropertyValue
    164 N2d0481a7069f4a44b0b4fc7a5e9ae485 rdf:first sg:person.01227445510.72
    165 rdf:rest N4d6459edf9c24990bb13681963206468
    166 N3283bedd9dfc4b7ca6bd624024619f9c rdf:first sg:person.01202757101.13
    167 rdf:rest N42013e149a204b43b06a76932d6b6504
    168 N42013e149a204b43b06a76932d6b6504 rdf:first sg:person.013003741441.64
    169 rdf:rest N2d0481a7069f4a44b0b4fc7a5e9ae485
    170 N49355ce9145048dbbf0f65406909870d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Kaplan-Meier Estimate
    172 rdf:type schema:DefinedTerm
    173 N4d6459edf9c24990bb13681963206468 rdf:first sg:person.01073375756.64
    174 rdf:rest Nde7d9bdacf6545d2b2be03dfc99e0b49
    175 N4f4f41824bec48eab92674d58362dce7 rdf:first sg:person.01252560751.47
    176 rdf:rest N5acec6d614034d48a38ed2f68672ac9e
    177 N5151057c7cba48c8b3608f52e9b38351 rdf:first sg:person.01004561122.13
    178 rdf:rest Na2acfd573dd34fae80600b571ffbc31d
    179 N5acec6d614034d48a38ed2f68672ac9e rdf:first sg:person.01131024035.33
    180 rdf:rest N76cb8b81fd9a41a690a8aff6bc85807a
    181 N5f3ff7618cc54925ada3e7b2e060ecd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Adult
    183 rdf:type schema:DefinedTerm
    184 N6280da8c4b704d0f84473e9f82bef06a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name Translocation, Genetic
    186 rdf:type schema:DefinedTerm
    187 N6f9db2d610ca4cd589ff3e0c6e6db26b rdf:first sg:person.01327063503.03
    188 rdf:rest N1ed2c897e5bf4dfcb707a2ff37c24c9f
    189 N6fcaab14cf5346e6a3827b31303b4543 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Genomics
    191 rdf:type schema:DefinedTerm
    192 N71308b0636ac483ca4af2f3f5bc9c1c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    193 schema:name Adolescent
    194 rdf:type schema:DefinedTerm
    195 N76cb8b81fd9a41a690a8aff6bc85807a rdf:first sg:person.016563315207.95
    196 rdf:rest Naeef19c2ed57428aae61c9438f4fa946
    197 N78f1fcc04e384e5aaca5cf8b272403e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    198 schema:name Antineoplastic Agents, Immunological
    199 rdf:type schema:DefinedTerm
    200 N81e6ce5803144115a5ea7f59c7f5cbac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    201 schema:name Retrospective Studies
    202 rdf:type schema:DefinedTerm
    203 N8916de8adc1c440fbb160d5ccc8eaf91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    204 schema:name Child
    205 rdf:type schema:DefinedTerm
    206 N8dc2727f21e94973a46811dd77e7d390 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    207 schema:name Microphthalmia-Associated Transcription Factor
    208 rdf:type schema:DefinedTerm
    209 N97c8313b753948d0bb83504c1df25bb9 schema:volumeNumber 6
    210 rdf:type schema:PublicationVolume
    211 N9d3df86ef4244545bb1e69622e75ea81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    212 schema:name Immunomodulation
    213 rdf:type schema:DefinedTerm
    214 Na2562641f9d745bfa6ba7f378a8975ae schema:name Springer Nature - SN SciGraph project
    215 rdf:type schema:Organization
    216 Na2acfd573dd34fae80600b571ffbc31d rdf:first sg:person.01236645411.07
    217 rdf:rest rdf:nil
    218 Na726c0470e2f49f39b7e2d3518dee01d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    219 schema:name Young Adult
    220 rdf:type schema:DefinedTerm
    221 Na741db344a4c43c1bc88fd1ab6dd5c59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    222 schema:name Kidney Neoplasms
    223 rdf:type schema:DefinedTerm
    224 Na7c8cbbd42924829a4ec90818772b02a schema:name dimensions_id
    225 schema:value pub.1110911755
    226 rdf:type schema:PropertyValue
    227 Na8cef5dc81bc4722818fe461589e8cb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    228 schema:name Carcinoma, Renal Cell
    229 rdf:type schema:DefinedTerm
    230 Naeef19c2ed57428aae61c9438f4fa946 rdf:first sg:person.01155331400.39
    231 rdf:rest N5151057c7cba48c8b3608f52e9b38351
    232 Nb0ccdbd87a6e46d29f8c441589e140d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    233 schema:name Child, Preschool
    234 rdf:type schema:DefinedTerm
    235 Nb40d7cac071342889b6bc86c50ac249d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    236 schema:name Aged
    237 rdf:type schema:DefinedTerm
    238 Nb89033efb64b413584d069849192bc2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    239 schema:name Treatment Outcome
    240 rdf:type schema:DefinedTerm
    241 Nbcb0390d7c1349548b9a7ca12df43738 schema:issueNumber 1
    242 rdf:type schema:PublicationIssue
    243 Nc8de4895737c4dddac2767c007878858 rdf:first sg:person.0663317655.45
    244 rdf:rest N4f4f41824bec48eab92674d58362dce7
    245 Ncc5a3e7d1b04443db668543eaad665f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    246 schema:name Middle Aged
    247 rdf:type schema:DefinedTerm
    248 Nd038508809bd456ca0761fd92ac0e577 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    249 schema:name Female
    250 rdf:type schema:DefinedTerm
    251 Nd86fc25903ca4600879421c3bcbdd400 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    252 schema:name Neoplasm Staging
    253 rdf:type schema:DefinedTerm
    254 Ndcee60b24692473b9445a87dfe8486fd rdf:first sg:person.0577111044.36
    255 rdf:rest Nebc8599a90864e8abd1891a22128c3d0
    256 Nde7d9bdacf6545d2b2be03dfc99e0b49 rdf:first sg:person.0675207541.34
    257 rdf:rest Ndcee60b24692473b9445a87dfe8486fd
    258 Ne133c6d98803403594301f4f6ad64ad8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    259 schema:name Humans
    260 rdf:type schema:DefinedTerm
    261 Ne2c7077a2414407381d9fda35d2c4e33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    262 schema:name Protein Kinase Inhibitors
    263 rdf:type schema:DefinedTerm
    264 Nebc8599a90864e8abd1891a22128c3d0 rdf:first sg:person.01051777752.35
    265 rdf:rest N6f9db2d610ca4cd589ff3e0c6e6db26b
    266 Nebe9d7835bb64f9f91bb2a82d15eee17 rdf:first sg:person.01102635440.48
    267 rdf:rest N09bd1e5de10a46b596eb8add25ca3272
    268 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    269 schema:name Biological Sciences
    270 rdf:type schema:DefinedTerm
    271 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
    272 schema:name Genetics
    273 rdf:type schema:DefinedTerm
    274 sg:grant.2438793 http://pending.schema.org/fundedItem sg:pub.10.1186/s40425-018-0482-z
    275 rdf:type schema:MonetaryGrant
    276 sg:journal.1049249 schema:issn 2051-1426
    277 schema:name Journal for ImmunoTherapy of Cancer
    278 schema:publisher BMJ
    279 rdf:type schema:Periodical
    280 sg:person.01004561122.13 schema:affiliation grid-institutes:grid.240145.6
    281 schema:familyName Tannir
    282 schema:givenName Nizar M.
    283 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004561122.13
    284 rdf:type schema:Person
    285 sg:person.01051777752.35 schema:affiliation grid-institutes:grid.240614.5
    286 schema:familyName George
    287 schema:givenName S.
    288 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051777752.35
    289 rdf:type schema:Person
    290 sg:person.01073375756.64 schema:affiliation grid-institutes:grid.508487.6
    291 schema:familyName Oudard
    292 schema:givenName S.
    293 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073375756.64
    294 rdf:type schema:Person
    295 sg:person.01102635440.48 schema:affiliation grid-institutes:grid.412807.8
    296 schema:familyName Chism
    297 schema:givenName D. D.
    298 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102635440.48
    299 rdf:type schema:Person
    300 sg:person.01131024035.33 schema:affiliation grid-institutes:grid.413776.0
    301 schema:familyName Coulomb-L’hermine
    302 schema:givenName A.
    303 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131024035.33
    304 rdf:type schema:Person
    305 sg:person.01155331400.39 schema:affiliation grid-institutes:None
    306 schema:familyName Choueiri
    307 schema:givenName T. K.
    308 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155331400.39
    309 rdf:type schema:Person
    310 sg:person.01202757101.13 schema:affiliation grid-institutes:grid.411439.a
    311 schema:familyName Boilève
    312 schema:givenName A.
    313 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202757101.13
    314 rdf:type schema:Person
    315 sg:person.01227445510.72 schema:affiliation grid-institutes:grid.11843.3f
    316 schema:familyName Barthélémy
    317 schema:givenName P.
    318 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227445510.72
    319 rdf:type schema:Person
    320 sg:person.01236645411.07 schema:affiliation grid-institutes:grid.11843.3f
    321 schema:familyName Malouf
    322 schema:givenName Gabriel G.
    323 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236645411.07
    324 rdf:type schema:Person
    325 sg:person.01252560751.47 schema:affiliation grid-institutes:None
    326 schema:familyName Bosse
    327 schema:givenName D.
    328 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252560751.47
    329 rdf:type schema:Person
    330 sg:person.013003741441.64 schema:affiliation grid-institutes:grid.51462.34
    331 schema:familyName Carlo
    332 schema:givenName M. I.
    333 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013003741441.64
    334 rdf:type schema:Person
    335 sg:person.01327063503.03 schema:affiliation grid-institutes:grid.417829.1
    336 schema:familyName Chevreau
    337 schema:givenName C.
    338 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327063503.03
    339 rdf:type schema:Person
    340 sg:person.01337717664.13 schema:affiliation grid-institutes:grid.413776.0
    341 schema:familyName Landman-Parker
    342 schema:givenName J.
    343 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337717664.13
    344 rdf:type schema:Person
    345 sg:person.016563315207.95 schema:affiliation grid-institutes:grid.240145.6
    346 schema:familyName Su
    347 schema:givenName Xiaoping
    348 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016563315207.95
    349 rdf:type schema:Person
    350 sg:person.0577111044.36 schema:affiliation grid-institutes:grid.51462.34
    351 schema:familyName Voss
    352 schema:givenName M. H.
    353 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577111044.36
    354 rdf:type schema:Person
    355 sg:person.0616232204.47 schema:affiliation grid-institutes:grid.468189.a
    356 schema:familyName Amin
    357 schema:givenName A.
    358 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616232204.47
    359 rdf:type schema:Person
    360 sg:person.0643123146.91 schema:affiliation grid-institutes:grid.413776.0
    361 schema:familyName Tabone
    362 schema:givenName M-D
    363 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643123146.91
    364 rdf:type schema:Person
    365 sg:person.0663317655.45 schema:affiliation grid-institutes:grid.189967.8
    366 schema:familyName Bilen
    367 schema:givenName M. A.
    368 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663317655.45
    369 rdf:type schema:Person
    370 sg:person.0675207541.34 schema:affiliation grid-institutes:grid.417812.9
    371 schema:familyName Borchiellini
    372 schema:givenName D.
    373 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675207541.34
    374 rdf:type schema:Person
    375 sg:pub.10.1038/nature12222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050842404
    376 https://doi.org/10.1038/nature12222
    377 rdf:type schema:CreativeWork
    378 sg:pub.10.1038/nchembio.1403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027422113
    379 https://doi.org/10.1038/nchembio.1403
    380 rdf:type schema:CreativeWork
    381 sg:pub.10.1038/ng.997 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018041741
    382 https://doi.org/10.1038/ng.997
    383 rdf:type schema:CreativeWork
    384 sg:pub.10.1038/nrurol.2014.162 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002943543
    385 https://doi.org/10.1038/nrurol.2014.162
    386 rdf:type schema:CreativeWork
    387 sg:pub.10.1186/s40425-018-0319-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100689551
    388 https://doi.org/10.1186/s40425-018-0319-9
    389 rdf:type schema:CreativeWork
    390 grid-institutes:None schema:alternateName Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
    391 schema:name Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
    392 rdf:type schema:Organization
    393 grid-institutes:grid.11843.3f schema:alternateName Department of Hematology and Oncology, Centre Hospitalier Universitaire de Strasbourg, 1, Place de l’Hôpital, 67000, Strasbourg, France
    394 Service d’Hématologie et d’Oncologie, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France
    395 schema:name Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France
    396 Department of Hematology and Oncology, Centre Hospitalier Universitaire de Strasbourg, 1, Place de l’Hôpital, 67000, Strasbourg, France
    397 Department of Medical Oncology, Hôpital Universitaire Pitié-Salpétrière, Paris, France
    398 Service d’Hématologie et d’Oncologie, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France
    399 rdf:type schema:Organization
    400 grid-institutes:grid.189967.8 schema:alternateName Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA
    401 schema:name Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA
    402 rdf:type schema:Organization
    403 grid-institutes:grid.240145.6 schema:alternateName Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    404 Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    405 schema:name Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    406 Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    407 rdf:type schema:Organization
    408 grid-institutes:grid.240614.5 schema:alternateName Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
    409 schema:name Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
    410 rdf:type schema:Organization
    411 grid-institutes:grid.411439.a schema:alternateName Department of Medical Oncology, Hôpital Universitaire Pitié-Salpétrière, Paris, France
    412 schema:name Department of Medical Oncology, Hôpital Universitaire Pitié-Salpétrière, Paris, France
    413 rdf:type schema:Organization
    414 grid-institutes:grid.412807.8 schema:alternateName Division of Hematology and Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA
    415 schema:name Division of Hematology and Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA
    416 rdf:type schema:Organization
    417 grid-institutes:grid.413776.0 schema:alternateName Service d’Anatomopathologie, Hôpital Armand-Trousseau, Paris, France
    418 Service d’Hématologie et d’Oncologie Pédiatrique, Hopital Armand-Trousseau, Paris, France
    419 schema:name Service d’Anatomopathologie, Hôpital Armand-Trousseau, Paris, France
    420 Service d’Hématologie et d’Oncologie Pédiatrique, Hopital Armand-Trousseau, Paris, France
    421 rdf:type schema:Organization
    422 grid-institutes:grid.417812.9 schema:alternateName Centre Antoine Lacassagne, Nice, France
    423 schema:name Centre Antoine Lacassagne, Nice, France
    424 rdf:type schema:Organization
    425 grid-institutes:grid.417829.1 schema:alternateName IUCT-Oncopole, Institut Claudius-Regaud, Toulouse, France
    426 schema:name IUCT-Oncopole, Institut Claudius-Regaud, Toulouse, France
    427 rdf:type schema:Organization
    428 grid-institutes:grid.468189.a schema:alternateName Carolinas Healthcare System, Levine Cancer Institute, Charlotte, NC, USA
    429 schema:name Carolinas Healthcare System, Levine Cancer Institute, Charlotte, NC, USA
    430 rdf:type schema:Organization
    431 grid-institutes:grid.508487.6 schema:alternateName U790 PARCC, European Georges Pompidou Hospital, René Descartes University, Paris, France
    432 schema:name Association pour la Recherche sur les Thérapeutiques Innovantes en Cancérologie, Paris, France
    433 Oncology Department, European Georges Pompidou Hospital, René Descartes University, Paris, France
    434 U790 PARCC, European Georges Pompidou Hospital, René Descartes University, Paris, France
    435 rdf:type schema:Organization
    436 grid-institutes:grid.51462.34 schema:alternateName Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    437 schema:name Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    438 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...